UK markets closed

Aptose Biosciences Inc. (0UI8.L)

LSE - LSE Delayed price. Currency in CAD
Add to watchlist
2.6000-4.2700 (-62.15%)
At close: 03:52PM BST
Currency in CAD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 3-73.78%
S&P500 52-week change 321.23%
52-week high 39.9150
52-week low 30.0000
50-day moving average 36.4617
200-day moving average 36.4617

Share statistics

Avg vol (3-month) 3330
Avg vol (10-day) 3198
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 812.52M
% held by insiders 119.71%
% held by institutions 17.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.066667:1
Last split date 306 Jun 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-102.23%
Return on equity (ttm)-293.95%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -52.27M
Net income avi to common (ttm)-51.21M
Diluted EPS (ttm)-0.8750
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.25M
Total cash per share (mrq)0.59
Total debt (mrq)1.01M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.78
Book value per share (mrq)-0.37

Cash flow statement

Operating cash flow (ttm)-44.59M
Levered free cash flow (ttm)-25.82M